Disposition of amodiaquine and desethylamodiaquine in HIV-infected Nigerian subjects on nevirapine-containing antiretroviral therapy.

Scarsi, K; Fehintola, F; Ma, Q; Aweeka, F; Darin, K; Morse, G; Akinola, I; Adedeji, W; Lindegardh, N; Tarning, J; Ojengbede, O; Adewole, I; Taiwo, B; Murphy, R; Akinyinka, O; Parikh, S

Journal article

Disposition of amodiaquine and desethylamodiaquine in HIV-infected Nigerian subjects on nevirapine-containing antiretroviral therapy.

Abstract:: OBJECTIVES: Artesunate plus amodiaquine is used for malaria treatment in regions with overlapping HIV endemicity. Co-administration of artesunate/amodiaquine with antiretroviral therapy (ART) may result in drug-drug interactions, but minimal data exist. This study evaluated the impact of nevirapine-based ART, containing a backbone of zidovudine and lamivudine, on the disposition of amodiaquine and its active metabolite, desethylamodiaquine (DEAQ). METHODS: This was an open-label, parallel-group pharmacokinetic comparison between HIV-infected, adult subjects receiving steady-state nevirapine-based ART (n = 10) and ART-naive subjects (control group, n = 11). All subjects received a loose formulation of artesunate/amodiaquine (200/600 mg) daily for 3 days, with serial pharmacokinetic sampling over 96 h following the final dose of artesunate/amodiaquine. Amodiaquine and DEAQ were quantified using a validated HPLC method with UV detection. Pharmacokinetic parameters were determined using standard non-compartmental methods. RESULTS: Exposures to both amodiaquine and DEAQ were significantly lower in the nevirapine-based ART group compared with the control group (amodiaquine AUC₀₋₂₄ 145 versus 204 ng·h/mL, P = 0.02; DEAQ AUC₀₋₉₆ 14,571 versus 21,648 ng·h/mL, P < 0.01). The AUCDEAQ/AUC(amodiaquine) ratio was not different between groups (ART group 116 versus control group 102, P = 0.67). CONCLUSIONS: Subjects on nevirapine-based ART had lower exposure to both amodiaquine and DEAQ (28.9% and 32.7%, respectively). Consequently, this may negatively impact the effectiveness of artesunate/amodiaquine in HIV-infected individuals on this ART combination.

Publication status:: Published

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Share
Cite

Cite this record

APA Style

Scarsi, K., Fehintola, F., Ma, Q., Aweeka, F., Darin, K., Morse, G., Akinola, I., Adedeji, W., Lindegardh, N., Tarning, J., Ojengbede, O., Adewole, I., Taiwo, B., Murphy, R., Akinyinka, O., & Parikh, S. (2014). Disposition of amodiaquine and desethylamodiaquine in HIV-infected Nigerian subjects on nevirapine-containing antiretroviral therapy. Journal of Antimicrobial Chemotherapy, 69(5), 1370–1376.

MLA Style

Scarsi, K, et al. “Disposition of Amodiaquine and Desethylamodiaquine in HIV-Infected Nigerian Subjects on Nevirapine-Containing Antiretroviral Therapy.” Journal of Antimicrobial Chemotherapy, vol. 69, no. 5, 2014, pp. 1370–76.

Chicago Style

Scarsi, K, F Fehintola, Q Ma, et al. 2014. “Disposition of Amodiaquine and Desethylamodiaquine in HIV-Infected Nigerian Subjects on Nevirapine-Containing Antiretroviral Therapy.” Journal of Antimicrobial Chemotherapy 69 (5): 1370–76.
Print